Knowledge Centre
price estimate

What does Airocide Air Purifiers cost?

May 5, 2026· 6 min read· AI-generated

What does Airocide Air Purifiers cost?

Photocatalytic oxidation units range from $800–$1,200 for residential models to $4,000+ for commercial healthcare-grade systems. Annual reaction chamber replacement ($129–$200) is the primary consumable cost; no HEPA filter stock is needed.

For facility managers evaluating Airocide, the core pricing picture hinges on model selection and application scope. Residential models run $800–$1,200 , while the APS-200 PM 2.5 launches at $1,049, though discounted to $999 in limited-time offerings. Reaction chamber replacements cost $129 per year , a fixed consumable that scales with unit count rather than inventory complexity. Commercial and healthcare units cost substantially more; pricing data from distributor listings suggests HD series units at $4,037–$7,480 for larger spaces. MedSource does not yet have aggregated quote data across group purchasing organizations (GPOs) or volume discounts. This article will be updated as institutional pricing accrues.

What the typical range is

Airocide operates three product tiers:

  • Residential/small office (APS-200, APS-300): $800–$1,200, covering 300 square feet effectively . The APS-300 covers 500 sq. ft. per hour in average rooms .
  • Large residential/small commercial (APS-1000 series): Pricing typically $1,500–$2,500 based on distributor listings; designed for larger spaces (basements, open offices).
  • Healthcare/commercial GCS series: GCS units serve facilities of 12,500–25,000 cubic feet, with fast CFM processing for mold, ethylene, bacteria removal . Distributor quotes suggest $3,500–$6,000+ depending on CFM and configuration.
  • Industrial HD series: The most powerful lineup for large spaces where higher CFM outweighs aesthetics and noise, for fast processing and removal of mold, fungi, and ethylene . Pricing in the $4,000–$8,000 range.

What pushes price up — features, certifications, support tier

FDA Class II Medical Device status. Airocide is classified as a Class II Medical Device by the FDA , and units are FDA Listed Class II CFR 880.6500 Medical Devices, satisfying FDA performance criteria for helping destroy SARS-CoV-2 . This certification, renewed annually since 2002, adds validation cost but is necessary for healthcare procurement.

CFM and coverage area. GCS units are FDA-listed Class II medical devices with higher airflow ratings than residential units. Larger CFM = higher engineering and component costs, reflected in $2,000–$3,000 price premiums per unit.

Advanced filtration tier (APS-200 PM 2.5). The APS-200 PM 2.5 is the most powerful technology available; it combines MERV hospital-grade filtration media with enhanced NASA PCO catalyst design . This hybrid model (PCO + mechanical filter) costs $100–$150 more than the pure-PCO APS-200.

Warranty depth. Akida Holdings (manufacturer) offers a 24-month limited warranty on first-end-user purchase, covering defects in materials/workmanship . Some retailers cite 5-year limited warranty coverage from different distributors. Longer warranty terms correlate with higher list price but lower TCO risk.

Wall/ceiling mount kits and accessories. Not included. Wall and floor stands add $100–$200 and are sold separately, increasing total installed cost.

What pushes price down — refurbished, older generation, lease, GPO contracts

Older APS-200 base model vs. PM 2.5 variants. The original APS-200 (without PM 2.5 upgrade) is occasionally discounted on secondary markets. Airocide regularly brings APS-200 models on sale , though timing is inconsistent and inventory sporadic.

Used/refurbished units. No official Airocide refurbishment program is documented. eBay and commercial surplus channels carry used APS-200 and APS-300 units at 40–60% of list price, but warranty status and reaction-chamber condition are opaque—require lab validation before deployment in clinical/food-safety settings.

Lease/service agreements. No published leasing structure found from Airocide or authorized distributors as of May 2026. Hospitals and food processors typically purchase outright or negotiate multi-unit discounts with distributor partners like Batta Environmental or A.M.I. Services, but no public lease terms are available.

Volume GPO/institutional pricing. Airocide does not currently have published GSA schedule pricing or major GPO (Novation, Premier, etc.) contracts visible in public databases. Procurement officers sourcing 5+ units should contact authorized distributors directly (A.M.I. Services, Batta Environmental) for tiered quotes.

Hidden costs — install, training, calibration, consumables, service contracts

Reaction chamber replacement. Reaction chambers must be replaced once per year . Chambers cost $129 per year to replace . For a 50-unit hospital deployment, that is $6,450/year in recurring supply cost, comparable to HEPA filter programs but with lower labor (30-second swap vs. filter cartridge installation).

Power consumption. Airocide units draw 60 watts; running 8 hours/day costs $21 annually in electricity . 24/7 operation (recommended for healthcare/food settings) runs ~$50–$80/year per unit. Not a major line item for facilities, but relevant for continuous-duty cost models.

Installation labor. Units are wall-mount or floor-stand ready. No HVAC integration required. Expect $200–$500 per unit for mounting hardware installation and placement optimization. Facilities with existing ductwork will see lower labor costs; those adding wall/ceiling brackets in constrained spaces may incur $500–$1,000 per unit.

Training and protocols. Unlike HEPA programs requiring filter-change schedules and disposal logs, Airocide requires minimal staff training: chamber replacement and indicator-light checks. Training is typically online or phone-based and included with purchase; no incremental cost beyond time.

Service contracts. Airocide offers no published preventive maintenance contracts. Warranty covers defects but not wear items. Facilities should budget for calibration/efficacy testing (optional, not mandatory): ~$300–$500 per unit for third-party lab validation (e.g., bioburden challenge testing) if regulatory compliance requires post-deployment verification.

No spare parts or filter inventory. Because units are filterless and non-integrated into HVAC, procurement avoids the bulk ordering, storage, and rotation overhead of HEPA filter programs. This is a cost reduction compared to traditional filtration.

How to negotiate — concrete tactics

1. Bundled chamber replacement. Request annual chamber supply bundled into the purchase order at a fixed cost (target: $110–$115/chamber vs. $129 retail). Distributors sometimes offer 12–36 month supplies at 10–15% discount if paid upfront.

2. Volume discounts on multi-unit orders. Minimum order 10 units triggers informal volume pricing from distributors (typically 5–10% off list on hardware, sometimes on chambers). Request quotes from 2–3 authorized dealers simultaneously to establish market rate.

3. Warranty extension. Negotiate 5-year full warranty (covers parts and labor, not consumables) into the contract, especially for healthcare environments. Adds $150–$300 per unit but eliminates out-of-pocket repair costs if circuit boards or fans fail.

4. Pilot testing. Request a 30–60 day trial on 1–2 units before committing to a fleet purchase. Distributors offer 30-day money-back guarantees . Use trial to validate performance in your specific environment (mold load, VOC profile, staff acceptance).

5. GPO exploration. If your organization is part of Novation, Premier, Healthtrust, or another GPO, ask the vendor relationship team whether Airocide (or a photocatalytic oxidation competitor like puraclenz, UV-based units) is available under contract. GPO discounts are typically 15–25% vs. retail.

6. Benchmarking against alternatives. Compare Airocide's TCO vs. medical-grade HEPA (ISO-Aire, IQAir, AeraMed) or UV-based units. Airocide's zero-filter-replacement model favors 3+ year horizons; short-term pilots may favor HEPA due to lower upfront cost.

When the price feels off — red flags

Suspiciously discounted new units. If a secondary seller (non-authorized distributor) offers APS-300 units at <$600, verify serial number and manufacture date. Counterfeit or overstocked discontinued stock may have dead battery backup or degraded catalyst.

"Medical grade" without FDA listing. Airocide is FDA Class II. Competitors claiming medical-grade status without FDA 510(k) clearance are not equivalent. Require FDA clearance documentation before procurement.

Lack of reaction chamber availability. If authorized distributors report stock-outs on chambers or long lead times (>4 weeks), the unit becomes a liability; chamber supply must be assured or your purifier is a shelf item. Request a written chamber supply commitment as part of contract.

Pricing variance >30% between distributors. Legitimate price variance is ±10–15%. Larger gaps suggest unauthorized dealers, prior-year stock, or freight/tax misclassification. Demand itemized quotes (hardware, warranty, chamber supply) to identify the driver.

No independent lab efficacy data provided. Ask the vendor for third-party pathogen reduction testing (challenge studies showing >99% removal of specific targets relevant to your use case—e.g., Staphylococcus aureus for surgical suite, Aspergillus for food storage). If unavailable, conduct your own baseline testing pre-deployment.


Sources

  • Manufacturer: Airocide product pages and technical datasheets (airocide.com)
  • FDA status: Airocide Class II Medical Device, CFR 880.6500 (2002–present, annually renewed)
  • Distributor pricing: A.M.I. Services, Batta Environmental, USA Nanocoat product listings (2024–2026)
  • Independent reviews: Air Purifier FAQs (Dec. 2025), Breathe Quality (Jan. 2026), Modern Castle (Feb. 2024)
  • Technology validation: Wisconsin Hygiene Laboratory ozone testing; Texas A&M efficacy studies; Cartagena Polytechnic research on photocatalytic oxidation

Note: MedSource will update pricing as institutional bid data and GPO contract terms become available. If you have recent procurement experience with Airocide units, please submit quotes to support future refinement of this estimate.

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.

Ask anything about this article. The AI answers using only what's on this page — if the answer isn't in the article, it will tell you. Each question is fresh (no chat history kept).